Us Peripheral Vascular Devices Accessories Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The U.S. peripheral vascular devices accessories market encompasses the instruments, consumables, and components used during endovascular procedures to treat blockages, aneurysms, and narrowing in peripheral arteries and veins. With a 2025 market value of $4.67 billion, this segment of the cardiovascular medical technology industry supports a wide range of clinical interventions from diagnostic angiography to complex revascularization procedures.

• •Market valued at $4.67 billion in 2025 with steady expansion across treatment sites
• •Covers accessories including sheaths, introducers, connectors, and disposal systems used alongside primary devices
• •Supported by high procedural volume across major U.S. hospital systems and ambulatory surgical centers

A primary driver of market growth is the increasing prevalence of peripheral artery disease and chronic venous insufficiency among the aging U.S. adult population, combined with elevated rates of obesity, diabetes, and tobacco use. Technological advancements enabling less invasive treatment options, along with favorable reimbursement environments for outpatient peripheral interventions, are accelerating adoption rates and expanding the addressable patient population.

• •Rising disease burden linked to aging demographics and lifestyle-related risk factors
• •Growing preference for minimally invasive endovascular approaches over open surgical procedures
• •Expansion of outpatient and office-based vascular intervention settings supported by reimbursement

The market spans multiple product categories including guidewires, catheters, sheaths, and closure devices, with hospitals representing the largest end-user segment while ambulatory surgical centers and physician offices are growing rapidly. The United States dominates the North American market due to advanced healthcare infrastructure, high procedural volumes, and established regulatory pathways through the FDA, with concentration highest in densely populated regions and major metropolitan hospital networks.

• •Hospitals account for the majority share of device and accessory consumption
• •Ambulatory surgery centers and office-based labs represent the fastest-growing distribution channel
• •Regional demand concentrated in states with large population bases and specialized vascular surgery programs

What are the recent trends and outlook?

Ongoing innovation in bioresorbable materials, advanced catheter technologies, and integrated delivery systems is expected to sustain the projected 6.5% annual growth trajectory through the forecast period. Increasing adoption of atherectomy devices, drug-coated technologies, and AI-assisted procedural planning tools may further expand the accessories market as treatment paradigms evolve toward more personalized and efficient vascular care models.

• •Product innovation in device materials and coating technologies expected to drive replacement cycles
• •Expanding use of AI and imaging guidance tools during peripheral procedures may increase accessory consumption
• •Long-term growth supported by continued disease prevalence and minimally invasive treatment preference